These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8957707)

  • 21. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
    Péan JM; Boury F; Venier-Julienne MC; Menei P; Proust JE; Benoit JP
    Pharm Res; 1999 Aug; 16(8):1294-9. PubMed ID: 10468034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
    Yang MB; Tamargo RJ; Brem H
    Cancer Res; 1989 Sep; 49(18):5103-7. PubMed ID: 2766281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
    Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
    J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
    Ciftci K; Hincal AA; Kas HS; Ercan TM; Sungur A; Guven O; Ruacan S
    Pharm Dev Technol; 1997 May; 2(2):151-60. PubMed ID: 9552441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled release of macromolecules from PLA microspheres: using porous structure topology.
    Ehtezazi T; Washington C
    J Control Release; 2000 Sep; 68(3):361-72. PubMed ID: 10974390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release of nerve growth factor from a polymeric implant.
    Powell EM; Sobarzo MR; Saltzman WM
    Brain Res; 1990 May; 515(1-2):309-11. PubMed ID: 2357568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo characteristics of injectable poly(DL-lactic acid) microspheres for long-acting drug delivery.
    Kobayashi D; Tsubuku S; Yamanaka H; Asano M; Miyajima M; Yoshida M
    Drug Dev Ind Pharm; 1998 Sep; 24(9):819-25. PubMed ID: 9876532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.
    Zeng W; Huang J; Hu X; Xiao W; Rong M; Yuan Z; Luo Z
    Int J Pharm; 2011 Dec; 421(2):283-90. PubMed ID: 22001532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of erythropoietin-dextran microparticle-based PLGA/PLA microspheres on RGCs.
    Rong X; Yang S; Miao H; Guo T; Wang Z; Shi W; Mo X; Yuan W; Jin T
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6025-34. PubMed ID: 22871834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of release rate of tetanus vaccine from polyester microspheres.
    Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
    Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):527-34. PubMed ID: 9876618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
    J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextran retention in the rat brain following release from a polymer implant.
    Dang W; Saltzman WM
    Biotechnol Prog; 1992; 8(6):527-32. PubMed ID: 1282018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of and drug release from a novel 2,2-bis(2-oxazoline) linked poly(lactic acid) polymer.
    Tarvainen T; Karjalainen T; Malin M; Pohjolainen S; Tuominen J; Seppälä J; Järvinen K
    J Control Release; 2002 Jun; 81(3):251-61. PubMed ID: 12044565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK; Park TG
    J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotrophin releasing single and multiple lumen nerve conduits.
    Yang Y; De Laporte L; Rives CB; Jang JH; Lin WC; Shull KR; Shea LD
    J Control Release; 2005 Jun; 104(3):433-46. PubMed ID: 15911044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.